-
Pre-Open Stock Movers 06/28: (NTLA) (AVXL) (EDIT) Higher; (GTEC) (XPO) (CCL) Lower (more...)
-
Tech, health stocks rise, cyclicals fall on prospects of divided U.S. Congress
-
Pre-Open Stock Movers 10/05: (MYOK) (KOS) (EIDX) Higher; (BBIO) (AMC) (DKNG) Lower (more...)
-
Regeneron Announces Investor Conference Presentations
-
Regeneron Announces Pricing of Public Offering of Senior Unsecured Notes
-
Sanofi announces closing of Regeneron stock sale
-
Regeneron Completes Secondary Offering of Common Stock Held by Sanofi
-
Regeneron (REGN) Prices 11.8M Share Registered Direct Offering by Sanofi (SNY) at $515/Sh
-
Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares
-
Sanofi announces pricing of Regeneron stock offering
-
UPDATE: Citi Downgrades Regeneron Pharma (REGN) to Neutral
-
Citi Upgrades Regeneron Pharma (REGN) to Buy
-
Citi Assumes Regeneron Pharma (REGN) at Neutral
-
Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
-
Regeneron Pharma (REGN) PT Raised to $396 at Citi
-
Regeneron Pharma (REGN) PT Raised to $388 at Citi
-
S&P keeps New Year's rally alive, Dow eases
-
Citi Downgrades Regeneron Pharma (REGN) to Neutral
-
UPDATE: Regeneron Pharma (REGN) PT Lowered to $480 at Citi Citing Promising Pipeline
-
Regeneron Pharma (REGN) PT Raised to $575 at Citi
-
Pre-Open Movers 06/26: (STOR) (PTLA) (P) Higher; (NEOT) (MTNB) (GRUB) Lower (more...)
-
Citigroup Comments On Regeneron (REGN)
-
Pre-Open Stock Movers 01/06: (ETRM) (OGXI) (STML) Higher; (RT) (GIII) (REGN) Lower (more...)
-
Citi Starts Regeneron Pharma (REGN) at Buy
-
Pre-Open Stock Movers 06/10: (HCC) (CTIC) (HIMX) Higher; (BDBD) (ESPR) (FRAN) Lower (more...)
-
Viking Global Shows New Stakes in AMBEV (ABEV), Anthem (ANTM) NXP Semi (NXPI) (more...)
-
Notable Analyst Rating Changes 2/17: (SRPT) (MU) (CCG) Upgraded; (IMAX) (CVC) (JWN) Downgraded
-
Notable Analyst Rating Changes 04/16: (SFUN) (TWTR) (YELP) Upgraded; (INTC) (UNH) (GDP) Downgraded
-
Citi Upgrades Regeneron Pharma (REGN) to Buy
-
Notable Analyst Rating Changes 02/12: (CROX) (S) (ZTS) Upgraded; (AMZN) (DF) (GMCR) Downgraded
-
Notable Analyst Rating Changes 07/12: (FFIV) (REGN) (XLNX) Upgraded; (SODA) (APOL) (PFE) Downgraded
-
StreetInsider.com Pre-Open Movers 01/17: (KSWS) (NLS) (CBS) Higher; (PWER) (CLSN) (COLM) Lower (more...)
-
Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
-
Notable 52-Week Highs and Lows of the Day 09/21: (REGN) (OPTR) (RRC) High; (ANR) (WLT) (MS) Low
-
Notable Analyst Rating Changes 09/09: (DB) (SUN) (TWX) Upgraded; (RIMM) (REGN) (SNY) Downgraded
-
Regeneron (REGN) Shares Higher Ahead of Citi's Biotech Meeting Tomorrow
-
Citi Downgrades Regeneron Pharma (REGN) to Hold
-
Citi Starts Regeneron Pharma (REGN) at Buy, $68 Price Target
-
Morning Movers 11/22: APRI, MAGS, REGN, GMCR, CRUS, PTEK, CTRN, CPWM Higher; IRE, NBG Lower
-
Regeneron Pharma (REGN) Announces 4.5M Common Offering
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)

